AI for Knowledge Management in the Pharmaceutical Sector
THE PROBLEM
A global pharmaceutical company involved in researching, developing and distributing innovative therapies manages vast volumes of technical and scientific documentation generated across every stage of the drug development lifecycle.
During testing and regulatory review, authorities frequently request additional details or supplementary documentation, making it essential to retrieve specific information quickly from thousands of files, both internal and from public records.
The complexity and dispersion of this content slowed R&D activities, increased operational risk and had a direct impact on time –to market.
THE SOLUTION
The company adopted Expert.ai hybrid AI solution to strengthen knowledge discovery and intelligence processes across its scientific, regulatory and operational functions.
The solution applies advanced semantic analysis and natural language understanding to automatically extract relevant concepts from scientific documentation, clinical reports, regulatory materials and public data sources.
The platform:
- Indexes and semantically enriches internal documentation
- Enables immediate retrieval of information needed for regulatory submissions and inquiries
- Automatically identifies approvals issued by regulatory authorities (such as the FDA)
- Triggers internal workflows to accelerate response and dossier preparation activities
Integration with enterprise systems like Microsoft SharePoint supports standardized knowledge management and makes it accessible to R&D, regulatory, compliance and product development teams.
ADVANTAGES
- Better use and sharing of corporate knowledge
- More efficient support forregulatory intelligence and compliance activities
- Reduced operational risk through faster retrieval of critical documentation
- Accelerated response times to regulatory authorities
- Easy integration with existing corporate applications
AI you can explain. Outcomes you can measure.
Let expert.ai show you how to apply AI—securely, transparently and at scale.